Target intelligence / Profile preview

Venom allergen protein (None commonly used; sometimes abbreviated as VAP or VAL (Venom Allergen-like protein) in scientific literature, but not universally.)

Target
None commonly used; sometimes abbreviated as VAP or VAL (Venom Allergen-like protein) in scientific literature, but not universally.
Molecular classification
Secreted protein, Allergen, Enzyme (some variants, e.g. serine proteases, phospholipase), Cysteine-rich secretory protein/Antigen 5/Pathogenesis-related 1 (CAP superfamily)
01

Overview

Venom allergen proteins comprise a diverse family of secreted proteins found in the venoms of hymenopteran insects (such as bees, wasps, ants), parasitic nematodes, and other organisms. These proteins belong primarily to the CAP superfamily, characterized by cysteine-rich domains. They are potent immunomodulators and allergens, responsible for triggering IgE-mediated hypersensitivity reactions in humans and animals, including systemic anaphylaxis[4][5]. Beyond their role in allergy, venom allergen proteins from parasites (e.g., nematodes, wasps) manipulate host immune and defense responses, facilitating infection and colonization[2][3][1][6]. Some have enzyme activity, while others act as binding proteins or immunomodulators. Their medical relevance includes use in allergy diagnostics, therapeutic immunotherapy, and as models for understanding host-parasite interactions. Safety concerns revolve around their high allergenicity and potential for severe immune reactions.

Other names
Venom allergen-like protein (VAL or VAP)CAP superfamily protein (Cysteine-rich secretory proteins/Antigen 5/Pathogenesis-related 1)Antigen 5 (Api m 6 in bees, Rcr3^pim^ in tomato, Ac-ASP-1 in nematodes)Api m 10, Api m 11 (bee venom variants)Vn50 (in parasitic wasps)
02

Mechanism of action

Immunotherapeutic desensitization: Induction of tolerance by exposure to purified venom allergen proteins. Immune modulation: Blocking IgE-mediated recognition or downstream signaling in allergic reactions. Parasite facilitation: Suppressing or hijacking host immune responses to promote infection.

03

Biological functions

Allergy and immune response modulationSuppression or activation of host defense (in parasites, insects, nematodes)Enzymatic activity (endopeptidase, phospholipase)Melanization inhibition (in insect hosts)Tissue remodelingCell signaling (via interaction with immune receptors)
04

Disease associations

Allergy (including systemic and anaphylactic reactions)Infection (facilitating nematode or parasitoid invasion in plants/animals)InflammationImmune-mediated responses and hypersensitivityOther (potential for immunomodulation in host-parasite interactions)
05

Safety considerations

High risk of allergic reactions, including severe systemic anaphylaxisVariable efficacy and safety in immunotherapy depending on allergen purity and formulationCross-reactivity risks due to molecular similarity among different species' venom allergensPotential off-target effects in diagnostic or therapeutic use
06

Interacting drugs

Allergen immunotherapies targeting specific venom proteins (e.g., venoms from bee, ant, wasp)

3 more in the full profile.

07

Biomarkers

Allergen-specific IgE (serum immunoglobulin E levels)Component-resolved diagnostics (e.g., Api m 1, Api m 4, Ves v 5 for bee/wasp venom allergy)Expression levels in host or parasite tissue (used in research)

Beyond the preview

Go deeper on Venom allergen protein (None commonly used; sometimes abbreviated as VAP or VAL (Venom Allergen-like protein) in scientific literature, but not universally.).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Venom allergen protein (None commonly used; sometimes abbreviated as VAP or VAL (Venom Allergen-like protein) in scientific literature, but not universally.).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call